FR3012141B1 - NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
FR3012141B1
FR3012141B1 FR1360121A FR1360121A FR3012141B1 FR 3012141 B1 FR3012141 B1 FR 3012141B1 FR 1360121 A FR1360121 A FR 1360121A FR 1360121 A FR1360121 A FR 1360121A FR 3012141 B1 FR3012141 B1 FR 3012141B1
Authority
FR
France
Prior art keywords
agomelatin
crystals
preparing
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1360121A
Other languages
French (fr)
Other versions
FR3012141A1 (en
Inventor
Hanbin Shan
Yuhui Shen
Ying Luo
Philippe Letellier
Michael Lynch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Laboratoires Servier SAS
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1360121A priority Critical patent/FR3012141B1/en
Application filed by Shanghai Institute of Pharmaceutical Industry, Laboratoires Servier SAS filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to EP14749937.0A priority patent/EP3036218B1/en
Priority to US14/908,253 priority patent/US9663451B2/en
Priority to CN201480042990.3A priority patent/CN105473551B/en
Priority to PL14749937T priority patent/PL3036218T3/en
Priority to MEP-2019-153A priority patent/ME03388B/en
Priority to ES14749937T priority patent/ES2734562T3/en
Priority to RS20190633A priority patent/RS58778B1/en
Priority to SG11201600005VA priority patent/SG11201600005VA/en
Priority to PT14749937T priority patent/PT3036218T/en
Priority to RU2016106954A priority patent/RU2695609C2/en
Priority to JP2016530589A priority patent/JP6525996B2/en
Priority to NZ716153A priority patent/NZ716153A/en
Priority to PCT/FR2014/051972 priority patent/WO2015015118A2/en
Priority to DK14749937.0T priority patent/DK3036218T3/en
Priority to LTEP14749937.0T priority patent/LT3036218T/en
Priority to UAA201601716A priority patent/UA117023C2/en
Priority to CA2918228A priority patent/CA2918228C/en
Priority to MX2016001218A priority patent/MX369301B/en
Priority to AU2014298230A priority patent/AU2014298230C1/en
Priority to SI201431215T priority patent/SI3036218T1/en
Priority to HUE14749937 priority patent/HUE044798T2/en
Priority to EA201600143A priority patent/EA031053B1/en
Publication of FR3012141A1 publication Critical patent/FR3012141A1/en
Publication of FR3012141B1 publication Critical patent/FR3012141B1/en
Application granted granted Critical
Priority to ZA2016/00196A priority patent/ZA201600196B/en
Priority to HK16110305.1A priority patent/HK1222167A1/en
Priority to HK16111559.2A priority patent/HK1223348A1/en
Priority to HRP20191119TT priority patent/HRP20191119T1/en
Priority to CY20191100686T priority patent/CY1122959T1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR1360121A 2013-07-31 2013-10-17 NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Expired - Fee Related FR3012141B1 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR1360121A FR3012141B1 (en) 2013-10-17 2013-10-17 NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UAA201601716A UA117023C2 (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
CN201480042990.3A CN105473551B (en) 2013-07-31 2014-07-30 New model, preparation method and the pharmaceutical composition comprising it of the eutectic of agomelatine and p-methyl benzenesulfonic acid
PL14749937T PL3036218T3 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
MEP-2019-153A ME03388B (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid1 method for preparing same and tue pharmaceutical compositions containing same
ES14749937T ES2734562T3 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulfonic acid, their preparation process and pharmaceutical compositions containing them
CA2918228A CA2918228C (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
SG11201600005VA SG11201600005VA (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
PT14749937T PT3036218T (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
RU2016106954A RU2695609C2 (en) 2013-07-31 2014-07-30 Novel forms of agomelatine and n-toluenesulphonic acid co-crystals, method for preparing thereof and pharmaceutical compositions containing thereof
JP2016530589A JP6525996B2 (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulfonic acid, processes for their preparation and pharmaceutical compositions containing them
NZ716153A NZ716153A (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
PCT/FR2014/051972 WO2015015118A2 (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
DK14749937.0T DK3036218T3 (en) 2013-07-31 2014-07-30 CO-CRYSTALS OF AGOMELATIN AND P-TOLUENSULPHONIC ACID, PROCEDURE FOR THEIR MANUFACTURING AND PHARMACEUTICAL PARTICULARS CONTAINING THESE
EP14749937.0A EP3036218B1 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
LTEP14749937.0T LT3036218T (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
RS20190633A RS58778B1 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
MX2016001218A MX369301B (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same.
AU2014298230A AU2014298230C1 (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
SI201431215T SI3036218T1 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
HUE14749937 HUE044798T2 (en) 2013-07-31 2014-07-30 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
EA201600143A EA031053B1 (en) 2013-07-31 2014-07-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and pharmaceutical compositions containing same
US14/908,253 US9663451B2 (en) 2013-07-31 2014-07-30 Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing them
ZA2016/00196A ZA201600196B (en) 2013-07-31 2016-01-11 NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THREOF
HK16110305.1A HK1222167A1 (en) 2013-07-31 2016-08-30 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
HK16111559.2A HK1223348A1 (en) 2013-07-31 2016-10-04 Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
HRP20191119TT HRP20191119T1 (en) 2013-07-31 2019-06-19 Co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
CY20191100686T CY1122959T1 (en) 2013-07-31 2019-07-01 CO-CRYSTALS OF AGOMELATIN AND P-TOLUOLESULFONIC ACID, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1360121A FR3012141B1 (en) 2013-10-17 2013-10-17 NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (2)

Publication Number Publication Date
FR3012141A1 FR3012141A1 (en) 2015-04-24
FR3012141B1 true FR3012141B1 (en) 2015-10-30

Family

ID=50179670

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1360121A Expired - Fee Related FR3012141B1 (en) 2013-07-31 2013-10-17 NOVEL FORMS OF CO-CRYSTALS OF AGOMELATIN AND P-TOLUENESULPHONIC ACID, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (1)

Country Link
FR (1) FR3012141B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702041B (en) * 2012-05-14 2013-08-14 上海右手医药科技开发有限公司 Agomelatine benzenesulfonic acid compound and preparation method thereof

Also Published As

Publication number Publication date
FR3012141A1 (en) 2015-04-24

Similar Documents

Publication Publication Date Title
FR3037956B1 (en) NOVEL AMINO ACID DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR3015483B1 (en) NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2986002B1 (en) NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR3046792B1 (en) NOVEL AMMONIUM DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR3037959B1 (en) NOVEL BICYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MA37206B1 (en) Novel pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
FR3002733B1 (en) NOVEL SALT OF THE ABEXINOSTAT, THE CRYSTALLINE FORM ASSOCIATED WITH THEM, THE PROCESS FOR PREPARING THEM AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR3008979B1 (en) NOVEL PHOSPHATE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR3001970B1 (en) PROCESS FOR THE PREPARATION OF DICARBOXYLIC 2,5-FURANE ACID
MA47179A (en) COMPOSITION OF MANNURONIC DICARBOXYLIC ACID
TN2012000266A1 (en) NOVEL CO-CRYSTALS OF AGOMELATIN, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT2517700E (en) Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
FR2988091B1 (en) PULVERULENT COMPOSITIONS OF A COMPLEX BETWEEN ACID AND METAL AND PROCESS FOR PREPARING THE SAME
MA52644A (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF DGLA ACID AND THEIR USE
MA40781A (en) PHARMACEUTICAL COMPOSITION OF LOW DOSAGE ISOTRETINOIN FOR ORAL USE
RU2019110980A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A 15-HEPC AND METHODS FOR TREATING ASTHMA AND LUNG DISEASES WITH THEIR APPLICATION
BR112019000187A2 (en) solid composition containing oral anticoagulant
MA45158A (en) PHARMACEUTICAL COMPOSITION CONSISTING OF ÉTEPLIRSEN
MA35002B1 (en) CRYSTALLINE DELTA FORM OF ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR3007405B1 (en) PROCESS FOR THE PREPARATION OF A COMPOSITION COMPRISING FUNCTIONALIZED SILICO / GERMANO-METALLIC PARTICLES AND COMPOSITION OBTAINED
FR3014437B1 (en) NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN
FR3006609B1 (en) CATALYST AND METHOD FOR SYNTHESIS OF GLYCOLIC ACID
FR2976284B1 (en) NOVEL CO-CRYSTALS OF AGOMELATIN, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2977495B1 (en) PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM WITH HIGH DRONEDARONE CONTENT AND PROCESS FOR PREPARING THE SAME
FR3034765B1 (en) NOVEL METHOD FOR THE SIMULTANEOUS SYNTHESIS OF AZELAIC ACID AND PELARGONIC ACID BY OZONE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20220605